Blue Nile Appears Highly Overvalued
Blue Nile’s stock (NILE) initially traded higher after reporting Q3 numbers at the beginning of November. While revenues were a bit disappointing (only meeting analysts' expectations), earnings were above estimates and 64% above the earnings from Q3 of 2006. Management was very upbeat on the conference call and even increased their 2007 guidance for both sales and earnings. Management now expects sales of $109 to 115m for Q4 and earnings of $0.40-0.45 leaving us with a full year 2007 number of $1.00 to $1.05.
While the headlines read “management raises guidance,” the fact is that the strength was largely in the third quarter and guidance for Q4 is not that impressive when comparing it to Q4 of 2006. If earnings come in at the top end of the range, it will represent a 15% increase annually which is far slower than its growth of previous quarters. While 15% growth is attractive, it hardly justifies a multiple of 70+ times current earnings which is where the stock is trading right now.
Digging into the conference call, I noticed that management stated much of the strength was from its international sales which were up an astounding 105% year over year. This sounds great until one realizes that the company re-launched its two international websites this year so of course the percentage gain would be significant given the anemic base international sales were starting from. While this could definitely be an area for the company to explore for growth, the numbers are fairly light at this point and there is little evidence that an international push is really gaining traction.
The company is flush with cash. Cash levels have risen to a point where there is $4.40 per share sitting in the bank. While Blue Nile has re-purchased shares in the past, analysts were surprised to note that this is the second quarter in a row that the company has not repurchased a single share. When asked about this fact, management said they would not be averse to using cash for share repurchases but wanted to wait for a more opportune time. This implies that management views the stock as at least somewhat overvalued and is holding their cash until they are able to employ it at lower price levels.
As mentioned, valuation is extremely high for the growth rate currently being observed. This is certainly no reason outright to short the stock, but the price pattern is shaping up to confirm what the fundamentals are saying. It would have been foolish to short NILE in the 70’s this summer as momentum was strong and traders continued to bid up the shares. But as we transition to a market that is showing weakness, and consumers are showing more signs of fatigue, NILE’s stock has begun to weaken and was not able to participate in the recent market strength. This is a telltale sign that institutions are not accumulating shares and serves as a red flag to anyone long this retail name.
Investors will likely be disappointed with the Q4 numbers and in the meantime, bad general data points for consumers should carry weight for this stock in particular.
Full disclosure: Author has a short position in NILE
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Apocalypse Dow: The Search for Scapegoats
- Reading the S&P 500's Crashing Waves
- On a Return to Normalcy: Dow 8,500
- Looking Back at Lehman: Lying, Scapegoating and a General Lack of Accountability
- iShares ETF Tracking Error: Risks and Explanations
- U.S. vs. the World: Sectors Matter
- Full list of Editor's Picks »
- Nation's Debt: It's Not Being Rescued, It's Being Moved Around »
- Clueless - Cramer's Mad Money (10/8/08) »
- Cramer Should Be Suspended »
- Crazy P/E Ratios »
- Sirius Shares Priced Like Stamps »
- Earnings Preview: General Electric »
- Wall Street Breakfast: Must-Know News »
- This Isn't a Bottom, It's a Disturbance in The Force »
- Cramer: Dow Could Drop Another 14%, Oil's Going to $50 »
- Similarities to U.S. 1937, Japan 1998 »
- 5 Reasons Stocks Will Keep Falling »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Midstream MLPs Crashing, Present Opportunity
- A Fresh Look at Shipping Company Stocks
- Panic Selling in InterOil: What Now?
- Potash Corp.: No Liquidity Problems Here
- The Year of the Bear
- Cobalt: More Than Just Blue
- Investors Can Find Comfort in Big Blue
- Hershey: The Perfect Recession Investment?
- Applied Materials Leads by Example
- Full list of Long Ideas »
- The Short Case for General Electric
- Too Late to Short SPY? An Historical Perspective
- Henderson Group: Profit Warning Surprises Short Investors
- Decreasing Chipotle Traffic Could Spell Trouble
- Why I Sold Lowe's Short
- Accor, Host and Marriott: Short Interest Heats Up
- Global Financial Crisis Makes Oil a Great Hedge
- Michael Page International: Stock Down on Market Weakness
- Gaming Stocks Still a Poor Bet - Barron's
- After Coming Rate Cuts, Some Appealing Short ETFs
- Full list of Short Ideas »
- Prefer a Yield - Cramer's Lightning Round (10/10/08)
- Bulls Take a Stand - Cramer's Stop Trading! (10/10/08)
- Clueless - Cramer's Mad Money (10/8/08)
- Torpedo Dry Ships - Cramer's Lightning Round (10/8/08)
- Chocolate Lover - Cramer's Mad Money (10/7/08)
- Yield is King - Cramer's Lightning Round (10/7/08)
- Goldman Disses Solar - Cramer's Stop Trading ! (10/7/08)
- Time to Hoard Cash - Cramer's Mad Money (10/6/08)
- Buyers On Strike - Cramer's Stop Trading! (10/6/08)
- Still Bullish on RIMM - Cramer's Lightning Round (10/6/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »



This article has 4 comments:
Scheidt
Thanks Boris - I got a different feel from managements call - didn't appear to be as optimistic as you imply. At any rate, it takes a whole lot of international expansion to justify the multiple.
Valseek - I think you're looking at sales and yes you are correct at 27% y/y growth. I am looking at EPS which management has guided to 0.45 at the top end versus 0.39 last year.
Thanks for the comments guys!